Status:
COMPLETED
Exercise on Multiple Sclerosis Patients
Lead Sponsor:
Petros Dinas
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Multiple sclerosis (MS) patients are characterized by thermoregulatory failure, known as Uthoff's phenomenon. Precisely, 60-80% of the MS patients present adverse clinical symptoms when their body tem...
Detailed Description
Multiple Sclerosis (MS) mostly affects young individuals aged between 20 to 40 years and is the leading cause of morbidity and disability in young. Most of the MS patients experience motor symptoms su...
Eligibility Criteria
Inclusion
- Postmenopausal women (no menses for the last year at least);
- Osteoporosis patients (female): T-score\<-2.5 at the femoral neck (or other anatomical site);
- Osteoporosis patients (male): T-score\<-2.5 at the femoral neck (or other anatomical site)
- Osteopenia patients (female): T-score\<-1.0 at the femoral neck (or other anatomical site);
- Osteopenia patients (male): T-score\<-1.0 at the femoral neck (or other anatomical site)
- Patients taking drugs/ supplements for osteoporosis will be accepted in the study after going through a wash-up period
Exclusion
- Women with irregular menses (i.e. with no established menopause)
- Patients taking medications for other diseases known to interfere with bone metabolism
- Patients with other chronic diseases (e.g. diabetes)
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04125628
Start Date
June 1 2019
End Date
June 25 2019
Last Update
October 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
FAME Lab, Department of Exercise Science, University of Thessaly
Trikala, Thessaly, Greece, 42100